Avalyn Pharma Inc. (NASDAQ:AVLN – Get Free Report) Director Jill Carroll purchased 277,778 shares of Avalyn Pharma stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $18.00 per share, with a total value of $5,000,004.00. Following the transaction, the director directly owned 2,186,562 shares in the company, valued at $39,358,116. This trade represents a 14.55% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Avalyn Pharma Stock Up 1.2%
Shares of AVLN stock opened at $29.84 on Friday. Avalyn Pharma Inc. has a 1 year low of $26.00 and a 1 year high of $30.20.
Recommended Stories
Receive News & Ratings for Avalyn Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalyn Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
